Pliant Therapeutics Inc.

NASDAQ: PLRX · Real-Time Price · USD
1.54
-0.03 (-2.22%)
At close: Aug 15, 2025, 3:59 PM
1.54
-0.32%
After-hours: Aug 15, 2025, 05:57 PM EDT

Pliant Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
71.19M 63.23M 33.69M 51.66M
Short-Term Investments
284.54M 431.01M 297.5M 148.93M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
1.92M 1.87M 394K 838K
Receivables
2.3M 3M 3.14M 2.47M
Inventory
n/a n/a n/a n/a
Other Current Assets
163K 1.27M 1.13M 975K
Total Current Assets
362.26M 505.5M 340.31M 209.44M
Property-Plant & Equipment
32.77M 4.78M 9.91M 10.94M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
34.69M 6.65M 10.3M 11.77M
Total Assets
396.95M 512.15M 350.61M 221.22M
Account Payables
5.96M 4.53M 1.58M 2.97M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 2.46M 1.87M
Other Current Liabilities
n/a 9.04M 10.22M 4.91M
Total Current Liabilities
33.22M 28.52M 23.91M 16.83M
Long-Term Debt
30.21M 10.05M 9.93M n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
59.65M 10.05M 13.36M 5.33M
Total Liabilities
92.87M 38.58M 37.27M 22.16M
Total Debt
60.19M 11.37M 15.81M 7.19M
Common Stock
6K 6K 5K 3K
Retained Earnings
-710.05M -499.75M -338.41M -215.09M
Comprehensive Income
321K 345K -1.96M -201K
Shareholders Equity
304.08M 473.58M 313.34M 199.06M
Total Investments
284.54M 431.01M 297.5M 148.93M